| Mrs Mary Jo Fuller, RPH | |
|
223 N Main St, Marion, SC 29571-3025 | |
| (843) 423-1882 | |
| (843) 423-5006 |
| Full Name | Mrs Mary Jo Fuller |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 223 N Main St, Marion, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134168362 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 3613 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Mary Jo Fuller, RPH 400 Devon Rd, Marion, SC 29571-1906 Ph: (843) 423-3136 | Mrs Mary Jo Fuller, RPH 223 N Main St, Marion, SC 29571-3025 Ph: (843) 423-1882 |
News Archive
InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries and other neurotrauma conditions, today announced that the U.S. Food and Drug Administration has approved the Company's Investigational Device Exemption to begin human studies to test its biopolymer scaffold product, a technology developed to treat patients with acute, traumatic SCI.
t2cure GmbH, a biopharmaceutical company developing and marketing stem cell-based regenerative therapies, announced today that the quality of its lead product t2c001 has been certified by the European Medicines Agency.
Inflammatory bowel disease is a chronic recurrent disease, which mainly consists of ulcerative colitis and Crohn's disease, and whose causes are as yet unclear. Many clinical and research studies have indicated that intestinal flora dysbacteriosis contributes to the pathogenesis of ulcerative colitis. Probiotics are non-pathogenic beneficial flora, which have important effects on maintaining the balance of intestinal flora.
Ludwig-Maximilian-Universitaet in Munich researchers have discovered a hitherto unknown molecular function of a specific microRNA that preserves integrity of the endothelium and reduces the risk of atherosclerosis.
A specific inhibitor of the small regulatory RNA-molecule "microRNA-100" can be used to stimulate the growth of new blood vessels, if a major artery is chronically occluded.
› Verified 3 days ago
Dr. Brittany Kirkland Page, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 N Main St, Marion, SC 29571 Phone: 843-423-1021 | |
Dr. Charles Wayne Wise Jr., PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2537b E Highway 76, Marion, SC 29571 Phone: 843-765-3320 | |
Dr. Christiana Keller, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 N Main St, Marion, SC 29571 Phone: 843-423-1021 | |
Josey Lecklitner, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 N Main St, Marion, SC 29571 Phone: 843-423-1021 | |
Spencer Gray, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 N Main St, Marion, SC 29571 Phone: 843-598-8132 | |
Debbie H Simmons, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2913 Cherrydale Rd, Marion, SC 29571 Phone: 843-423-9983 |